India has not achieved its target of eliminating tuberculosis by 2025, five years ahead of the global deadline, but it has been making strides, according to the World Health Organization's Global TB Report 2026, released on 12 November. The incidence and mortality due to the bacterial infection have been on the decline, even as the country remains far from the milestones it set for itself.

In 2018, Prime Minister Narendra Modi announced India's ambitious target of eliminating TB by 2025, five years ahead of the global target. Elimination is defined as less than one case per million population, a demanding standard for a country that accounts for roughly a quarter of the world's TB burden. The latest report confirms that the target has been missed, while recording measurable progress on deaths and diagnosis.

India reported a 38 percent reduction in its TB mortality as compared to 2015, breaching the 2020 End TB milestone of reducing it by 35 percent, albeit five years later. India's TB mortality reduced from 28 per lakh population in 2015 to 18 per lakh population in 2025, according to the Global TB report. The 2025 target of reducing mortality by 75 percent still remains distant.

The report recorded that 25.3 lakh people were diagnosed under the national programme in 2025, down from 26.18 lakh a year earlier, while deaths fell to 2.63 lakh from just over 3 lakh in 2024. The decline in deaths amounts to a 38 percent drop in TB mortality since the 2015 baseline, against a global decline of 35 percent over the same period.

Diagnosis is improving


India has seen an improvement in diagnosis, with more people accessing rapid diagnostics and getting tested for resistance to commonly used medicines. Rapid diagnostic testing expanded in 2025, with 46 percent of cases diagnosed using rapid tests. Quick diagnosis ensures timely treatment and prevents the further spread of the infection.

The national programme has inducted several new testing methodologies under its TB Mukt Bharat Abhiyan, and the country also saw a massive active case finding exercise over the last two years. The campaign approach, including the 100-Day TB Elimination Campaign launched in December 2024 across 347 districts, seeks to accelerate case detection, reduce diagnostic delays and strengthen treatment outcomes.

Funding has shifted towards domestic sources. With a decline in global health funding, and TB funding reducing by 14 percent globally, India saw an increase in domestic funding. The increased domestic funding in India, along with Indonesia and the Russian Federation, made up for most of the 9 percent rise in TB funding across low- and middle-income countries in 2025. India reported a low 0.79 percent share of global funding in its TB funding.

The missing incidence number


One notable gap in this year's report is that India's estimated TB incidence is missing. The WHO states that estimates of TB incidence and associated indicators are under review, pending finalisation and use of data from district-level sentinel surveillance, and that estimates are expected to be updated in early 2027.

New data from a district TB surveillance conducted in 2025 is currently being analysed to come up with new country-level estimates. A population-level TB disease prevalence survey was conducted in 2025 in 50 representative districts, and India has established a system for district-level sentinel surveillance of population-level trends in the prevalence of TB disease and infection. The Union government has also skipped its own annual India TB report, traditionally published in March around World TB Day, which carries detailed state-wise figures.

The End TB targets set by the WHO, with 2015 as the base year, aim to reduce TB deaths by 35 percent by 2020, 75 percent by 2025, 90 percent by 2030 and 95 percent by 2035, and to reduce TB incidence by 20 percent by 2020, 50 percent by 2025, 80 percent by 2030 and 90 percent by 2035. India has reached the first mortality milestone about five years behind schedule.

The global picture


Globally, an estimated 10.6 million people fell ill with TB in 2025 and 1.13 million died, still well short of the 2030 elimination goal. The global incidence rate was 129 cases per 100,000 people in 2025, down from 131 in 2024, a 1.6 percent drop. Over the past decade, TB incidence has fallen by 14 percent, far short of the 50 percent reduction target set by the End TB Strategy for 2025.

Funding remains the central constraint. In 2025, total funding for TB prevention, diagnosis and treatment reached $6.6 billion, just 30 percent of the $22 billion annual target for 2027, according to Dr Tereza Kasaeva, director at the WHO department for HIV, TB, hepatitis and sexually transmitted infections. Drug-resistant TB remains a significant challenge: in 2025, only 42 percent of the estimated 370,000 people with rifampicin-resistant TB received treatment, and around 2.2 million people were either undiagnosed or unreported.

Nearly 50 percent of TB patients and their households face catastrophic costs from the disease, the report notes. The WHO is urging countries to strengthen financing for TB prevention, diagnosis and treatment and to accelerate the development of new tools, warning that the drop in international funding could offset the gains made in TB care if it continues.